Related Experiment Video
Updated: Aug 2, 2026
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Pulmonary arteriovenous malformations related to Rendu-Osler-Weber syndrome
American Journal of Medical Genetics
|September 1, 1984
Summary
Rendu-Osler-Weber syndrome patients with pulmonary arteriovenous malformations can benefit from a new transvenous balloon occlusion treatment. This approach offers a safer alternative to surgery, improving management and preventing complications.
Area of Science:
- Genetics
- Cardiology
- Pulmonology
Background:
- Rendu-Osler-Weber (ROW) syndrome is an inherited disorder.
- Pulmonary arteriovenous malformations (AVM) affect approximately 50% of ROW patients.
- Traditional treatment for pulmonary AVMs involves thoracotomy with potential complications.
Observation:
- A family study of 33 members across four generations with ROW syndrome.
- Detailed review of clinical findings and therapeutic strategies over 25 years.
- Focus on early detection and prevention of major complications.
Findings:
- Transvenous occlusion of pulmonary AVMs using a silicone balloon is a safe and effective treatment.
- This minimally invasive technique avoids the risks associated with thoracotomy.
- The study highlights the varied manifestations of ROW syndrome.
Implications:
- New treatment options improve the management of pulmonary AVMs in ROW syndrome.
- Early detection and intervention can prevent severe complications.
- Genetic counseling is crucial for families affected by this inherited disorder.
